Medtecs International Corporation Limited (TPE:9103)
Taiwan · Delayed Price · Currency is TWD 4.930
-0.020 (-0.40%)
Aug 25, 2025, 1:35 PM CST
TPE:9103 Market Cap
TPE:9103 has a market cap or net worth of 1.62 billion as of August 25, 2025. Its market cap has decreased by -0.71% in one year.
Market Cap
1.62B
Enterprise Value
1.68B
Revenue
1.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
4.93
Market Cap Chart
Since October 7, 1999, TPE:9103's market cap has increased from 1.43B to 1.62B, an increase of 13.35%. That is a compound annual growth rate of 0.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 1.60B | -12.08% |
| Dec 31, 2024 | 1.82B | -22.67% |
| Dec 29, 2023 | 2.35B | -5.78% |
| Dec 30, 2022 | 2.50B | -36.48% |
| Dec 31, 2021 | 3.93B | -66.33% |
| Dec 31, 2020 | 11.68B | 2,482.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 294.69B |
| PharmaEssentia | 163.47B |
| Bora Pharmaceuticals Co., LTD. | 92.58B |
| Lotus Pharmaceutical | 51.02B |
| Oneness Biotech | 33.91B |
| Polaris Group | 33.28B |
| Lumosa Therapeutics | 33.19B |
| Center Laboratories | 27.67B |